 |
 |

Dietary Fats and the Risk of Incident Alzheimer Disease
Martha Clare Morris, ScD;
Denis A. Evans, MD;
Julia L. Bienias, ScD;
Christine C. Tangney, PhD;
David A. Bennett, MD;
Neelum Aggarwal, MD;
Julie Schneider, MD;
Robert S. Wilson, PhD
Arch Neurol. 2003;60:194-200.
Background Few studies have investigated the effects of dietary fats on the development of Alzheimer disease. We examined the associations between intake of specific types of fat and incident Alzheimer disease in a biracial community study.
Methods We performed clinical evaluations on a stratified random sample of 815 community residents aged 65 years and older who were unaffected by Alzheimer disease at baseline and who completed a food-frequency questionnaire a mean of 2.3 years before clinical evaluation.
Results After a mean follow-up of 3.9 years, 131 persons developed Alzheimer disease. Intakes of saturated fat and trans-unsaturated fat were positively associated with risk of Alzheimer disease, whereas intakes of -6 polyunsaturated fat and monounsaturated fat were inversely associated. Persons in the upper fifth of saturated-fat intake had 2.2 times the risk of incident Alzheimer disease compared with persons in the lowest fifth in a multivariable model adjusted for age, sex, race, education, and apolipoprotein E 4 allele status (95% confidence interval, 1.1-4.7). Risk also increased with consumption of trans-unsaturated fats, beginning with the second fifth of intake (relative risk, 2.4 compared with the lowest fifth; 95% confidence interval, 1.1-5.3). We observed linear inverse associations between Alzheimer disease and vegetable fat (P = .002), and, after further adjustment for other types of fat, marginally significant associations with intake of -6 polyunsaturated fat (P = .10 for trend) and monounsaturated fat (P = .10 for trend). Intakes of total fat, animal fat, and dietary cholesterol were not associated with Alzheimer disease.
Conclusion High intake of unsaturated, unhydrogenated fats may be protective against Alzheimer disease, whereas intake of saturated or trans-unsaturated (hydrogenated) fats may increase risk.
From the Rush Institute for Healthy Aging (Drs Morris, Evans, Bienias, Bennett, and Wilson), the Rush Alzheimer's Disease Center (Drs Evans, Bennett, Aggarwal, Schneider, and Wilson), and the Departments of Internal Medicine (Drs Morris, Evans, and Bienias), Preventive Medicine (Dr Morris), Clinical Nutrition (Dr Tangney), Neurological Sciences (Drs Bennett, Aggarwal, Schneider, and Wilson), and Psychology (Dr Wilson), Rush-Presbyterian/St Luke's Medical Center, Chicago, Ill.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort1,2
Poly et al.
Am J Clin Nutr 2011;94:1584-1591.
ABSTRACT
| FULL TEXT
Risk Factors and Preventive Interventions for Alzheimer Disease: State of the Science
Daviglus et al.
Arch Neurol 2011;68:1185-1190.
ABSTRACT
| FULL TEXT
Food Combination and Alzheimer Disease Risk: A Protective Diet
Gu et al.
Arch Neurol 2010;67:699-706.
ABSTRACT
| FULL TEXT
Risk factors for progressive supranuclear palsy: a case-control study in France
Vidal et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:1271-1274.
ABSTRACT
| FULL TEXT
Up-regulation of the {alpha}-secretase ADAM10 by retinoic acid receptors and acitretin
Tippmann et al.
FASEB J. 2009;23:1643-1654.
ABSTRACT
| FULL TEXT
Dementia Prevention: Methodological Explanations for Inconsistent Results
Coley et al.
Epidemiol Rev 2008;30:35-66.
ABSTRACT
| FULL TEXT
n-3 Fatty acid erythrocyte membrane content, APOE {varepsilon}4, and cognitive variation: an observational follow-up study in late adulthood
Whalley et al.
Am J Clin Nutr 2008;87:449-454.
ABSTRACT
| FULL TEXT
Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer's Disease (AD): Relevance to AD Prevention
Ma et al.
J. Neurosci. 2007;27:14299-14307.
ABSTRACT
| FULL TEXT
Dietary patterns and risk of dementia: The Three-City cohort study
Barberger-Gateau et al.
Neurology 2007;69:1921-1930.
ABSTRACT
| FULL TEXT
Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study
van Gelder et al.
Am J Clin Nutr 2007;85:1142-1147.
ABSTRACT
| FULL TEXT
Childhood intelligence and being a vegetarian
Richards
BMJ 2007;334:216-217.
FULL TEXT
Dietary Copper and High Saturated and trans Fat Intakes Associated With Cognitive Decline.
Morris et al.
Arch Neurol 2006;63:1085-1088.
ABSTRACT
| FULL TEXT
Fish Consumption and Cognitive Decline With Age in a Large Community Study
Morris et al.
Arch Neurol 2005;62:1849-1853.
ABSTRACT
| FULL TEXT
Dietary fatty acids and the risk of Parkinson disease: The Rotterdam Study
de Lau et al.
Neurology 2005;64:2040-2045.
ABSTRACT
| FULL TEXT
Perinatal {omega}-3 polyunsaturated fatty acid supply modifies brain zinc homeostasis during adulthood
Jayasooriya et al.
Proc. Natl. Acad. Sci. USA 2005;102:7133-7138.
ABSTRACT
| FULL TEXT
Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change
Morris et al.
Am J Clin Nutr 2005;81:508-514.
ABSTRACT
| FULL TEXT
Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline
Morris et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:1093-1099.
ABSTRACT
| FULL TEXT
Dietary fat intake and 6-year cognitive change in an older biracial community population
Morris et al.
Neurology 2004;62:1573-1579.
ABSTRACT
| FULL TEXT
Dietary intake of fatty acids and fish in relation to cognitive performance at middle age
Kalmijn et al.
Neurology 2004;62:275-280.
ABSTRACT
| FULL TEXT
Obesity and Alzheimer Disease: Roles of Diet and Genetics
Grant
Arch Intern Med 2004;164:109-110.
FULL TEXT
From the Library
Br J Ophthalmol 2003;87:1056-1056.
FULL TEXT
OTHER ARTICLES NOTED (24 Jan 03 to 18 Apr 03)
Evid. Based Nurs. 2003;6:e1-12.
FULL TEXT
Fish Consumption and the Risk of Alzheimer Disease: Is It Time to Make Dietary Recommendations?
Friedland
Arch Neurol 2003;60:923-924.
FULL TEXT
|